1. Home
  2. WKEY vs MRNS Comparison

WKEY vs MRNS Comparison

Compare WKEY & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKEY
  • MRNS
  • Stock Information
  • Founded
  • WKEY 1999
  • MRNS 2003
  • Country
  • WKEY Switzerland
  • MRNS United States
  • Employees
  • WKEY N/A
  • MRNS N/A
  • Industry
  • WKEY EDP Services
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKEY Technology
  • MRNS Health Care
  • Exchange
  • WKEY Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • WKEY 20.5M
  • MRNS 19.0M
  • IPO Year
  • WKEY N/A
  • MRNS 2014
  • Fundamental
  • Price
  • WKEY $2.39
  • MRNS $0.32
  • Analyst Decision
  • WKEY Strong Buy
  • MRNS Buy
  • Analyst Count
  • WKEY 1
  • MRNS 12
  • Target Price
  • WKEY $4.00
  • MRNS $4.28
  • AVG Volume (30 Days)
  • WKEY 47.7K
  • MRNS 1.8M
  • Earning Date
  • WKEY 09-30-2024
  • MRNS 11-12-2024
  • Dividend Yield
  • WKEY N/A
  • MRNS N/A
  • EPS Growth
  • WKEY N/A
  • MRNS N/A
  • EPS
  • WKEY N/A
  • MRNS N/A
  • Revenue
  • WKEY $20,985,000.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • WKEY N/A
  • MRNS $15.71
  • Revenue Next Year
  • WKEY $81.73
  • MRNS $40.57
  • P/E Ratio
  • WKEY N/A
  • MRNS N/A
  • Revenue Growth
  • WKEY N/A
  • MRNS 1.63
  • 52 Week Low
  • WKEY $1.55
  • MRNS $0.26
  • 52 Week High
  • WKEY $3.44
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • WKEY 66.30
  • MRNS 27.41
  • Support Level
  • WKEY $1.80
  • MRNS $0.30
  • Resistance Level
  • WKEY $2.09
  • MRNS $0.34
  • Average True Range (ATR)
  • WKEY 0.20
  • MRNS 0.03
  • MACD
  • WKEY 0.06
  • MRNS 0.05
  • Stochastic Oscillator
  • WKEY 98.73
  • MRNS 40.24

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: